Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enanta Pharmaceutica (NQ: ENTA )

13.23 -0.77 (-5.50%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 154,132
Open 13.87
Bid (Size) 11.99 (1)
Ask (Size) 13.35 (1)
Prev. Close 14.00
Today's Range 13.22 - 13.94
52wk Range 8.080 - 38.30
Shares Outstanding 21,055,392
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
From Enanta Pharmaceuticals, Inc.
Via Business Wire

Performance

YTD
+31.25%
+31.25%
1 Month
-2.07%
-2.07%
3 Month
+11.36%
+11.36%
6 Month
+37.10%
+37.10%
1 Year
-64.60%
-64.60%

More News

Read More
Recap: Enanta Pharma Q1 Earnings
Via Benzinga
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Earnings Scheduled For February 7, 2024
Via Benzinga
Earnings Preview For Enanta Pharma
Via Benzinga
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Enanta Pharmaceuticals Inc. (NASDAQ: ENTA) Near the Top of Equities by Percentage Gain on 11/21
Via Investor Brand Network
What 5 Analyst Ratings Have To Say About Enanta Pharma
Via Benzinga
Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Enanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Recap: Enanta Pharma Q4 Earnings
Via Benzinga
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ET
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Earnings Scheduled For November 20, 2023
Via Benzinga
Enanta Pharma Earnings Preview
Via Benzinga
Analyst Expectations for Enanta Pharma's Future
Via Benzinga
The Latest Analyst Ratings for Enanta Pharma
Via Benzinga
Enanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Full Year Ended September 30, 2023
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Enanta Pharmaceuticals to Host Virtual Key Opinion Leader Event to Discuss Advances in the Treatment Landscape for Respiratory Syncytial Virus (RSV) and its Proprietary RSV Pipeline
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Enanta Pharmaceuticals to Present Data for EDP-323, its Oral, Once-Daily, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus, at the 9th ESWI Influenza Conference
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Enanta Pharmaceuticals to Present Data for EDP-938, its Oral, Once-Daily, N-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus, at IDWeek™ 2023
From Enanta Pharmaceuticals, Inc.
Via Business Wire
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.